[Hyperlipidemia and atherosclerosis].

Area of Science:

• Cardiovascular Biology
• Immunology
• Molecular Medicine

Context:

• Atherosclerosis pathogenesis involves early monocyte recruitment to arterial walls.
• Macrophage-derived foam cells are key in early atherosclerotic lesions.
• Endothelial cell adhesion molecules (ICAM-1, VCAM-1, P-selecin) mediate monocyte attachment.

Purpose:

• To investigate the role of oxidized low-density lipoprotein (LDL) and its novel receptors in atherosclerosis.
• To characterize the expression and function of LOX-1 and SR-PSOX in the context of hyperlipidemia.
• To elucidate the significance of these molecular interactions in early atherogenesis.

Summary:

• Oxidized LDL, lysophosphatidylcholine, and oxidized fatty acids upregulate adhesion molecules and scavenger receptors (CD-36, SR-A, LOX-1).
• Novel oxidized LDL receptors, LOX-1 (on endothelial cells, smooth muscle cells, macrophages) and SR-PSOX (on macrophages), were identified.
• This research focuses on the critical involvement of hyperlipidemia, particularly oxidized LDL and its receptors, in the development of atherosclerosis.

Impact:

• Provides insights into molecular mechanisms driving early atherosclerosis.
• Identifies potential therapeutic targets (LOX-1, SR-PSOX) for preventing or treating atherosclerosis.
• Enhances understanding of the interplay between lipids, inflammation, and vascular cell biology in cardiovascular disease.